Fighting Triple Negative Breast Cancer with Innovation 🎗️

October is Breast Cancer Awareness Month, and I want to shed light on one of the toughest types to treat: Triple Negative Breast Cancer (TNBC).

Traditional treatments have shown limited success, and even newer targeted therapies haven’t made significant improvements for TNBC patients.

But there’s a glimmer of hope—and it’s called Pulse Electric Field Therapy, specifically with nanosecond pulsed fields like Nanopulston.

💡 Recent Research Highlights:

* ✅ Induced Cell Death: Increased apoptosis (programmed cell death) and necrosis in both lab (in vitro) and animal models (in vivo).

* ✅ Tumor Reduction: Studies found a significant reduction in tumor size for TNBC using Pulse Electric Field Therapy.

* ✅ Immune Activation: The therapy also boosts the production of chemokine CXCL9, which increases immune infiltration into the tumor microenvironment. This means that immune cells—especially cytotoxic T lymphocytes—can effectively target and destroy cancer cells.

Pulse Electric Field Therapy activates the immune system locally, training it to fight cancer cells and then sending these activated responses systemically through what’s known as the abscopal effect.

It’s cutting-edge, low-invasive, and represents the future of cancer treatment—brought to you today by the Williams Cancer Institute.

If you or a loved one are battling breast cancer, schedule a free consultation with us through the link in our bio. Let’s explore your options together, and take control of your journey towards healing.

Supporting Evidence:
• Xu Z, Pan C, Chen L, Qian J, Chen X, Zhou L, Zheng S. Nanosecond Pulsed Electric Field Induces an Antitumor Effect in Triple-Negative Breast Cancer via CXCL9 Axis Dependence in Mice. Cancers (Basel). 2023 Mar 30;15(7):2076. doi: 10.3390/cancers15072076.
• Campana LG, Daud A, Lancellotti F, Arroyo JP, Davalos RV, Di Prata C, Gehl J. Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation. Cancers (Basel). 2023 Jun 25;15(13):3340. doi: 10.3390/cancers15133340.), Pulsed electrical fields in combination with anti-PD1 and survival of mice with TNBC (EMT6) murine breast tumor. JCO41, 540-540(2023).DOI: • Ebtesam Nafie et al. (https://ascopubs.org/action/doSearch
10.1200/JCO.2023.41.16_suppl.540 (https://doi.org/10.1200/JCO.2023.41.16_suppl.540

#BreastCancerAwareness #TripleNegativeBreastCancer #TNBC #PulseElectricFieldTherapy #WilliamsCancerInstitute #InnovativeTherapy #CancerTreatment #BreastCancerResearch #ImmuneSystem #CancerFighter #HopeForHealing #IntegrativeOncology